EcoDrugPlus

Cyclin Dependent Kinase 1

Ensembl ID : ENSSLDG00000018654
Gene Symbol: CDK1
3 Cross references
247 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSSLDG00000004589
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSSLDG00000004155
Gene Symbol: CDK4
3 Cross references
238 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSSLDG00000013609
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSSLDG00000013030
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSSLDG00000002649
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSSLDG00000017475
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 2-Like

Ensembl ID : ENSSLDG00000006135
Gene Symbol: LOC111661064
2 Cross references
237 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSSLDG00000009489
Gene Symbol: CDA
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSSLDG00000015389
Gene Symbol: LOC111664285
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a27-Like

Ensembl ID : ENSSLDG00000022644
Gene Symbol: LOC111663275
3 Cross references
474 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSSLDG00000023977
Gene Symbol: LOC111645298
3 Cross references
535 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).